Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159026 · ClinicalTrials.gov registry record
Review of Charts From Amish/Mennonite Variant PA Patients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 38
- Enrollment target
NCT03159026: Completed study, sponsored by University of Pittsburgh.
NCT03159026 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03159026 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The natural history of patients with PA-AMV has not been systematically studied before and there is no published data in the literature about this condition since 1980. There is no evidence-based approach to care of these patients, particularly the younger patients who may no come to medical attention until significant cardiac problems develop. Through systematic review of existing medical records on essentially all known patient with this condition, investigators plan to develop an evidence-based management plan for preventive care of these patients.
Primary Outcome
Chart review to describe clinical and biochemical features of Amish/Mennonite PA variant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-04-06 |
| Est. Completion | 2022-09-05 |
What the finished NCT03159026 record still lists
NCT03159026 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03159026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03159026 about?
NCT03159026 is a clinical study titled "Review of Charts From Amish/Mennonite Variant PA Patients". The natural history of patients with PA-AMV has not been systematically studied before and there is no published data in the literature about this condition since 1980. There is no evidence-based approach to care of these patients, particularly the younger patients who may no come to medical attenti...
What is the current status of trial NCT03159026?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2017-04-06. Estimated completion is 2022-09-05.
Who is sponsoring clinical trial NCT03159026?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI